A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging.

Agnes JagerElisabeth G E de VriesC Willemien Menke-van der Houven van OordtPatrick NevenClasina M VenemaAndor W J M GlaudemansYamei WangRebecca G BagleyMaureen G ConlanPhilippe Aftimos

Published in: Breast cancer research : BCR (2020)

ClinicalTrials.gov, NCT02650817 . Registered on 08 January 2016.

Keyphrases

estrogen receptor
pet ct
metastatic breast cancer
positron emission tomography
high resolution
computed tomography
combination therapy
photodynamic therapy
smoking cessation